Traders Watch List - Merck & Co., Inc. (NYSE:MRK), MONITISE PLC (OTCMKTS:MONIF), Medbox Inc (OTCMKTS:MDBX), mCig Inc (OTCBB:MCIG)

Repost This

New York, NY -- (SBWIRE) -- 01/13/2014 -- Stock Professors is committed to provide its readers with best analytics on hot penny stocks. Our team of stock trading professional's mission is to analyze, track and rate the top penny stocks to buy in the market today. We realize how tough it is for the ordinary investor to make money in today’s volatile stock market. Some, probably like you turn to penny stocks in order to make huge gains on relatively little capital. Today’s hot Stocks to watch are: Merck & Co., Inc. (NYSE:MRK), MONITISE PLC (OTCMKTS:MONIF), Medbox Inc (OTCMKTS:MDBX), mCig Inc (OTCBB:MCIG)

Merck & Co., Inc. (NYSE:MRK) opened the session at $50.90, remained amid the day range of $50.79 - $52.88, and recently traded at $52.67. The stock showed a positive performance of 5.59% in the recent trading session. The stock gained a volume of 17.23 million shares and the average volume of the stock remained 9.83 million shares. Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures.

Will MRK Continue To Move Higher? Find Out Here

MONITISE PLC (OTCMKTS:MONIF) traded with volume of 2.82 million shares in the recent trading session and the average volume of the stock remained 3.45 million shares. The 52 week range of the stock remained $0.47- $1.38. The stock showed a negative movement of -2.24% and was recently trading at $1.31. The market capitalization of the stock remained 2.20 billion.

Has MONIF Found The Bottom And Ready To Gain Momentum? Find Out Here

Medbox Inc (OTCMKTS:MDBX) exchanged 383,517 shares and the average volume remained 210,334 shares. The stock escalated 26.87 % and was moving at $43.15. The beta of the stock remained -9.32. Medbox Inc. (Medbox) offers a machine that dispenses medication to individuals based on biometric identification (fingerprint sample). The machine allows pharmacies, hospitals, doctors' offices, and alternative medicine clinics to manage employee possession of sensitive drugs.

Why Should Investors Buy MDBX After The Recent Gain? Just Go Here and Find Out

mCig Inc (OTCBB:MCIG) gained volume of 7.41 million shares, while the average volume remained 3.01 million shares. The stock advanced 10.73% and remained at $0.227. The one month trend of the stock was 90.76% and the three month trend remained positive 92.37 %. mCig, Inc., formerly LifeTech Industries Inc., is a development-stage company. The Company is developing a day spa business in the areas of Montrose, California, surrounded by La Crescenta, La Canada and Glendale. The Company’s day spa focuses on women and men who equally enjoy the amenities and services of a full service day spa.

What was the Moving Force behind MCIG on Bullish Run? Read This Research Report

About Stock Professors:
We realize how tough it is for the ordinary investor to make money in today’s volatile stock market. That is why we offer penny stocks to watch and FREE stock picks to all our subscribers. We focus on undervalued and undiscovered penny stocks which are poised for not just short term but also long term growth. searches the market to bring you the best penny stocks. So, don’t wait any longer and subscribe to our FREE newsletter to get the hot penny stock picks delivered right in your email inbox!

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances.

The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: